Skip to main content

Table 1 Comparison between patients with true drug-resistant epilepsy (group I) and those with non-epileptic episodic events (group II) regarding clinical data

From: Long-term EEG monitoring and positron emission tomography in evaluating patients with drug-resistant epilepsy

  Group I Group II p value
(n 43) (n 24)
Age (years) 23.05 ± 5.42 21.7 ± 4.84 0.314
Sex Male 19 (63.3%) 11 (36.7%) 0.897
Female 24 (64.9%) 13 (35.1%)
Age of onset (years) 13.13 ± 3.68 14.53 ± 4.12 0.157
Duration of illness (years) 10.92 ± 4.85 6.17 ± 3.12 0.001*
Family history of epilepsy 12 (27.9%) 3 (12.5%) 0.02*
History of febrile convulsions 17 (39.5%) 2 (8.3%) 0.007*
Seizure frequency (per month) 10 ± 3.54 15 ± 4.58 < 0.0001*
Number of AEDs taken 10.92 ± 4.85 6.17 ± 3.12 < 0.0001*
Depressive symptoms (MADRS) 11 ± 1.83 17 ± 2.51 < 0.0001*
Anxiety symptoms (HAS) 13.41 ± 2.38 26 ± 4.72 < 0.0001*
  1. *Significant. AEDs: antiepileptic drugs, HAS: Hamilton Anxiety Scale, MADRS: Montgomery–Åsberg Depression Rating Scale